OKYO Pharma Limited
OKYO
$2.43
$0.062.53%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 0.00% | 24.38% | 0.00% | 66.54% | 0.00% |
| Total Depreciation and Amortization | 0.00% | 16.67% | 0.00% | -33.33% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00% | 12,720.41% | 0.00% | -99.76% | 0.00% |
| Change in Net Operating Assets | 0.00% | -132.99% | 0.00% | 99.92% | 0.00% |
| Cash from Operations | 0.00% | -550.21% | 0.00% | 91.05% | 0.00% |
| Capital Expenditure | 0.00% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00% | -- | -- | -- | -- |
| Total Debt Issued | 0.00% | 52,577.78% | 0.00% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00% | 110.15% | 0.00% | -75.10% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00% | 281.30% | 0.00% | -75.02% | 0.00% |
| Foreign Exchange rate Adjustments | 0.00% | 127.03% | 0.00% | 50.17% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00% | 257.73% | 0.00% | 120.29% | 0.00% |